BibTex RIS Cite

Patients’ attitude about generics – Bulgarian perspective

Year 2012, Volume: 16 Issue: 1, 36 - 40, 07.03.2014

Abstract

References

  • Sustaining Generic Medicines Markets in Europe. [On- line]. Available from: http://www.egagenerics.com/ doc/simoens-report_2006-04.pdf [Accessed: 22nd Nov2011].
  • Gaither CA, Kirking DM, Ascione FJ, Welage LS. Con- sumers’ views on generic medications. J Am Pharm As- soc 2001; 41:729-36.
  • Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43:472-9.
  • Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Am Pharm Assoc 2001:41:729-9.
  • Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal AE, Patrick – Miller L, Robitaille C. Illness representations: theoretical foundations. In: Percep- tion of health&illness. Editors: Petrie KJ, Weinman JA, Harwood Academic Publishers. Nederlands: 1997. P.19- 45(ISBN 90-5702-103-X).
  • Gross Domestic Product at Market Prices. [Online]. Available from: http://epp.eurostat.ec.europa.eu/tgm/ refreshTableAction.do?tab=table&plugin=1&init=1&pc ode=tec00001&language=en [Accessed: 22nd Nov2011].
  • The Role of Generic Medicines in Europe. European Ge- neric Medicines Association. [Online]. Available from: http://www.egagenerics.com/gen-geneurope.htm [Ac- cessed: 27th Nov2011].
  • IMS 2009. Data on file. [Corporate access].
  • Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J AM Pharm Assoc 2000; 40:378-83.
  • Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25:2875-90.
  • Tilyard MW, Dovey SM, Rosenstreich D. General practi- tioners’ views on generic medication and substitution. N Z Med J 1990; 103:318-20.
Year 2012, Volume: 16 Issue: 1, 36 - 40, 07.03.2014

Abstract

References

  • Sustaining Generic Medicines Markets in Europe. [On- line]. Available from: http://www.egagenerics.com/ doc/simoens-report_2006-04.pdf [Accessed: 22nd Nov2011].
  • Gaither CA, Kirking DM, Ascione FJ, Welage LS. Con- sumers’ views on generic medications. J Am Pharm As- soc 2001; 41:729-36.
  • Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43:472-9.
  • Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Am Pharm Assoc 2001:41:729-9.
  • Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal AE, Patrick – Miller L, Robitaille C. Illness representations: theoretical foundations. In: Percep- tion of health&illness. Editors: Petrie KJ, Weinman JA, Harwood Academic Publishers. Nederlands: 1997. P.19- 45(ISBN 90-5702-103-X).
  • Gross Domestic Product at Market Prices. [Online]. Available from: http://epp.eurostat.ec.europa.eu/tgm/ refreshTableAction.do?tab=table&plugin=1&init=1&pc ode=tec00001&language=en [Accessed: 22nd Nov2011].
  • The Role of Generic Medicines in Europe. European Ge- neric Medicines Association. [Online]. Available from: http://www.egagenerics.com/gen-geneurope.htm [Ac- cessed: 27th Nov2011].
  • IMS 2009. Data on file. [Corporate access].
  • Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J AM Pharm Assoc 2000; 40:378-83.
  • Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25:2875-90.
  • Tilyard MW, Dovey SM, Rosenstreich D. General practi- tioners’ views on generic medication and substitution. N Z Med J 1990; 103:318-20.
There are 11 citations in total.

Details

Primary Language English
Journal Section Articles
Authors

Hristina Lebanova This is me

Dimitar Manolov This is me

Ilko Getov This is me

Publication Date March 7, 2014
Published in Issue Year 2012 Volume: 16 Issue: 1

Cite

APA Lebanova, H., Manolov, D., & Getov, I. (2014). Patients’ attitude about generics – Bulgarian perspective. Marmara Pharmaceutical Journal, 16(1), 36-40. https://doi.org/10.12991/mpj.79357
AMA Lebanova H, Manolov D, Getov I. Patients’ attitude about generics – Bulgarian perspective. Marmara Pharm J. March 2014;16(1):36-40. doi:10.12991/mpj.79357
Chicago Lebanova, Hristina, Dimitar Manolov, and Ilko Getov. “Patients’ Attitude about Generics – Bulgarian Perspective”. Marmara Pharmaceutical Journal 16, no. 1 (March 2014): 36-40. https://doi.org/10.12991/mpj.79357.
EndNote Lebanova H, Manolov D, Getov I (March 1, 2014) Patients’ attitude about generics – Bulgarian perspective. Marmara Pharmaceutical Journal 16 1 36–40.
IEEE H. Lebanova, D. Manolov, and I. Getov, “Patients’ attitude about generics – Bulgarian perspective”, Marmara Pharm J, vol. 16, no. 1, pp. 36–40, 2014, doi: 10.12991/mpj.79357.
ISNAD Lebanova, Hristina et al. “Patients’ Attitude about Generics – Bulgarian Perspective”. Marmara Pharmaceutical Journal 16/1 (March 2014), 36-40. https://doi.org/10.12991/mpj.79357.
JAMA Lebanova H, Manolov D, Getov I. Patients’ attitude about generics – Bulgarian perspective. Marmara Pharm J. 2014;16:36–40.
MLA Lebanova, Hristina et al. “Patients’ Attitude about Generics – Bulgarian Perspective”. Marmara Pharmaceutical Journal, vol. 16, no. 1, 2014, pp. 36-40, doi:10.12991/mpj.79357.
Vancouver Lebanova H, Manolov D, Getov I. Patients’ attitude about generics – Bulgarian perspective. Marmara Pharm J. 2014;16(1):36-40.